Clients
Clients
"Hubtech21 is more a partner than just a consultant. For us, that made all the difference in helping us not only identify the steps we needed to take to develop a targeted operations plan in the crowded US market, but also modify and effectively roll-out that plan."
Gilles Riboulet, CEO, Amplitude Technologies
• AMPLITUDE TECHNOLOGIES – advanced solid-state lasers
• ARIANA PHARMA – decision support
“Boston is a privileged location to establish and develop relationships with prospects and clients. Throughout the seminars and contacts that Hubtech21 has been organizing for us, the US have become a major share in Ariana’s activities.” Mohammad Afshar, CEO Ariana Pharma
“Boston is a privileged location to establish and develop relationships with prospects and clients. Throughout the seminars and contacts that Hubtech21 has been organizing for us, the US have become a major share in Ariana’s activities.” Mohammad Afshar, CEO Ariana Pharma
• BIOCORTECH – drug development for psychiatric disorders
• BIOMETHODES – protein optimization
• BIOPROTEIN TECHNOLOGIES – protein production
• ESSONNE DEVELOPMENT AGENCY – economic development support to companies
• GENOMIC VISION – new diagnostics tools
• GENOPOLE – France’s leading Biotech cluster
• HYBRIGENICS – protein-protein Interaction detection
« The quality of organization and contact opportunities delivered match our ambitions. »
Didier Petiteville, Director of Operations Hybrigenics
« The quality of organization and contact opportunities delivered match our ambitions. »
Didier Petiteville, Director of Operations Hybrigenics
• HGH INFRARED SYSTEMS -manufacturer of optronic and infrared systems for defense, industrial and civil applications
• IMAGINE OPTIC – Shack-Hartmann wavefront sensing technologies for adaptive optics
• INSTITUT PASTEUR – Business Development and technology transfer department
• MAUNA KEA TECHNOLOGIES – imaging systems
« The Boston Office is the perfect base of operations for our development in the US. »
Benjamin Abrat, co-founder & Vice-President Mauna Kea Technologies
« The Boston Office is the perfect base of operations for our development in the US. »
Benjamin Abrat, co-founder & Vice-President Mauna Kea Technologies
• MERISTEM Protein production
• NOKAD – functional KO models in any mammalian species
• PARIS REGION ECONOMIC DEV. AGENCY – assistance in business settlements
• SINOVIA –Systems interoperability, hypervision
• UROGENE – urology drug discovery
• WATCHFROG – in vivo detection of chemical, pharmaceutical and cosmetic substances
• ZETA BIOTECH is a French young innovative company listed on Euronext since July 2007.
ZETA BIOTECH’s core competency is a new patented technology to preserve biomolecules and other products which can be used in several domains such as pharmaceutical industry, cosmetics, nutrition and biotechnology. The first product of ZETA BIOTECH is a unique electrophoresis precast gel with a reproductibility level significantly higher than existing gels.
ZETA BIOTECH’s core competency is a new patented technology to preserve biomolecules and other products which can be used in several domains such as pharmaceutical industry, cosmetics, nutrition and biotechnology. The first product of ZETA BIOTECH is a unique electrophoresis precast gel with a reproductibility level significantly higher than existing gels.
• Cellectis is the worldwide leader in the research, development and commercialization of rational genome engineering technologies. Cellectis proprietary technologies and platform are based upon a naturally occurring class of DNA endonucleases, the Meganucleases and DNA recombination.
Comments»
No comments yet — be the first.